| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.094 | 0.05 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.087 | 0.08 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.053 | 0.3 |